Introduction and historical perspective

Clinical Obstetrics and Gynecology

Volumn 46, Issue 1, 2003, Pages 125-131

  Wapner, Ronald J ^a   Waters, Thaddeus ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; CORTICOSTEROID; GLUCOCORTICOID; HYDROCORTISONE; SURFACTANT;

DRUG EFFECT; FETUS GROWTH; FETUS LUNG MATURATION; HISTORY; HUMAN; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN MORBIDITY; PREMATURITY; PRENATAL DRUG EXPOSURE; PRENATAL PERIOD; REVIEW; RISK BENEFIT ANALYSIS; STEROID THERAPY; SUBSTITUTION THERAPY; SURVIVAL;

BETAMETHASONE; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HISTORY, 20TH CENTURY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; PREGNANCY; PRENATAL CARE; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0038352362     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200303000-00017     Document Type: Review

References (50)

1. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998;339:313-320.
2. Crowley PA. 2000 Cochrane Database.
3. Liggins GC. Premature delivery of fetal lambs infused with glucocorticoids. J Endocrinol. 1969;45:515-523.
4. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50:515-525.
5. Liggins GC, Howie RN. Prevention of respiratory distress syndrome in premature infants by antepartum glucocorticoid treatment. In: Villee CA, Villee DB, Zuckerman J, eds. Respiratory distress syndrome. London: Academic Press, 1973:369-380.
6. Howie RN, Liggins GC. Clinical trials of antepartum betamethasone for prevention of respiratory distress in preterm infants. In: Preterm labor: Proceedings of the fifth Study Group of the Royal College of Obstetricians and Gynecologists. London: Royal College of Obstetricians and Gynecologists, 1977:281-289.
7. Gamsu H, Mullinger B, Donnai P, Dash C. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: Report of a UK multicenter trial. Br J Obstet Gynecol. 1989;96:401-410.
8. Block MF, Kling OR, Crosby WM. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant. Obstet Gynecol. 1977;50:186-190.
9. Dluholucky S, Babic J, Taufer J. Reduction of incidence and mortality of respiratory distress syndrome by administration of hydrocortisone to the mother. Arch Dis Child. 1976;51:420-423.
10. Doran TA, Swyer P, MacMurray B, et al. Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome. Am J Obstet Gynecol. 1980;136:313-320.
11. Kari MA, Hallman M, Eronen M, et al. Prenatal steroid in conjunction with human surfactant therapy: A randomized multicenter study. Pediatr Res. 1993;33:217A.
12. Morrison JC, Whybrew WD, Bucovaz ET, Schneider JM. Injection of corticosteroids to the mother to prevent neonatal respiratory distress syndrome. Am J Obstet Gynecol. 1978;13:358-366.
13. Papageorgiou AN, Desgranges MF, Masson M, et al. The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled double-blind study. Pediatrics. 1979;16:73-79.
14. Schutte MF, Treffers PE, Koppe JG, Breur W. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after premature labor. Br J Obstet Gynaecol. 1980;87:127-131.
15. Tauesch HW, Frigoletto F, Kitzmiller J, et al. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics. 1979;63:64-72.
16. Teramo K, Hallman M, Raivio KO. Maternal glucocorticoid in unplanned premature labor. Pediatr Res. 1980;14:326-329.
17. Schmidt PL, Sims ME, Strassner HT, et al. Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. Am J Obstet Gynecol. 1984;148:178-186.
18. Garite TJ, Rumney PJ, Briggs GG, et al. A randomized placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol. 1992;166:646-651.
19. Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1990;97:11-25.
20. Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 2, 1994. National Institutes of Health Consensus Development Conference Statement. Am J Obstet Gynecol. 1995;173:246-252.
21. ACOG Committee Opinion. Committee on Obstetric Practice: Antenatal corticosteroid therapy for fetal lung maturation. December 1994, No. 147.
22. NIH Consensus Development Conference Statement. Antenatal corticosteroids revisited: repeat courses. August 2000.
23. Elimian A, Verma U, Canterino J, et al. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol. 1999;93:174-179.
24. Fanaroff AA, Hack M. Periventricular leukomalacia-prospects for prevention [letter]. N Engl J Med. 1999;341:1229-1231.
25. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol. 1995;173:254-262.
26. Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med. 1999;341:1190-1196.
27. Mulder EJ, Derks JB, Visser GH. Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone [comment]. Br J Obstet Gynaecol. 1997;104:1239-1247.
28. Rotmensch S, Liberati M, Vishne TH, et al. The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities. A prospective randomized trial. Acta Obstet Gynecol Scand. 1999;78:493-500.
29. Derks JB, Mulder EJ, Visser GH. The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol. 1995;102:40-46.
30. Dunlop SA, Archer MA, Quinlivan JA, et al. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Maternal Fetal Med. 1997;6:309-313.
31. French NP, Hagan R, Evans SF, et al. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol. 1999;180:114-121.
32. Guinn DA, Atkinson MW, Sullivan L, et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA. 2001;286:1581-1587.
33. Kairalla AB. Hypothalamic-pituitary-adrenal axis function in premature neonates after extensive prenatal treatment with betamethasone: a case history. Am J Perinatol. 1992;9:428-430.
34. McKenna DS, Wittber GM, Nagaraja HN, Samuels P. The effects of repeat does of antenatal corticosteroids on maternal adrenal function. Am J Obstet Gynecol. 2000;183:669-673.
35. Johnson JW, Mitzner W, Beckjc Z, et al. Long-term effects of betamethasone on fetal development. Am J Obstet Gynecol. 1981;141:1053-1064.
36. Magness R, Hendricks S, Abbott D, et al. Repeated use betamethasone: Effects on adrenal function and birthweight in the rabbit. Am J Obstet Gynecol. 1996;174:A273, SPO.
37. Stewart JD, Gonzalez CL, Christensen HD, Rayburn WF. Impact of multiple antenatal doses of betamethasone on growth and development of mice offspring. Am J Obstet Gynecol. 1997;177:1138-1144.
38. Jobe AH, Wada N, Berry LM, et al. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol. 1998;178:880-885.
39. Horbar JD, Carpenter JH. Vermont Oxford Network 2000 Database Summary. Burlington, VT: Vermont Oxford Network; 2001.
40. Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. IS J Obstet Gynecol. 1998;179:1632-1639.
41. Vohr BR, Coll CG, Lobato D, et al. Neurodevelopmental and medical status of low-birthweight survivors of bronchopulmonary dysplasia at 10 to 12 years of age. Dev Med Child Neurol. 1991;33:690-697.
42. Jobe A. The new BPD: an arrest of lung development. Pediatr Res. 1999;46:641-643.
43. Groneck P, Reuss D, Goetze-Speer B, Speer CP. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr. 1993;122:938-944.
44. Gerdes JS, Harris MC, Polin RA. Effects of dexamethasone and indomethacin on elastase, alpha 1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr. 1988;113:727-731.
45. Watterberg, KL, Scott SM, Bakstrom C, et al. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics. 2000;105:320-324.
46. Gordon P, Rutledge J, Sawin R, et al. Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants. J Perinatol. 1999;19:573-577.
47. Solomon NS, Gartner H, Oesterreicher T, Henning S. Development of glucocorticoidresponsiveness in mouse intestine. Pediatr Res. 2001;49:782-788.
48. Okajima S, Matsuda T, Kazutoshi C, et al. Antenatal dexamethasone administration impairs normal postnatal lung growth in rats. Pediatr Res. 2001;49:777-781.
49. Benesova O, Pavlik A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacoclogy. 1989;28:89-97.
50. Howard H. Reductions in size and total DNA of cerebrum and cerebellum in adult mice after corticosteroid treatment in infancy. Exp Neurol. 1968;22:191-208.